TL;DR
Researchers have identified a new gene, PCDH1, as a significant contributor to bronchial hyperresponsiveness (BHR), a key characteristic of asthma. This discovery suggests that defects in the structural integrity of the airway epithelium, the body's first line of defense against inhaled irritants, may play a crucial role in the development of BHR and, consequently, asthma.
What Problem Does This Paper Address?
Asthma is a widespread chronic inflammatory airway disease affecting millions globally, driven by a complex interplay of genetic and environmental factors. A central feature of asthma is bronchial hyperresponsiveness (BHR), which signifies an exaggerated sensitivity of the airways to various stimuli. Previous research had already pointed to chromosome 5q31-q33 as a region harboring genes associated with BHR and asthma. However, the specific genes responsible remained largely unidentified. This paper aims to pinpoint a novel gene within this critical chromosomal region that contributes to BHR.
Methods
The study employed a multi-pronged approach:
- Positional Cloning and Linkage Analysis: Initially, the researchers used positional cloning in Dutch families with asthma to narrow down the genetic region of interest on chromosome 5q31-q33. They performed linkage analysis using microsatellite markers to identify regions with a significant statistical association with BHR.
- Fine Mapping and SNP Identification: Once a candidate region was identified, they used a dense map of single nucleotide polymorphisms (SNPs) for fine mapping. This allowed them to pinpoint specific genetic variations within the candidate region.
- Gene Resequencing: The PCDH1 gene, located within the identified critical region, was resequenced in a diverse set of individuals to identify novel sequence variants.
- Replication Studies: To validate their findings, the identified PCDH1 gene variants were tested for association with BHR in seven independent populations across the Netherlands, the United States, and the United Kingdom. These populations included general population samples, family studies, and case-control studies.
- Expression Analysis: The researchers investigated the presence and location of PCDH1 mRNA and protein in relevant tissues and cells. This was done using polymerase chain reaction (PCR), Western blotting, and immunohistochemistry.
Datasets
The study utilized several datasets:
- Dutch Families: A primary cohort of 200 families (1,259 individuals) with asthma was used for initial linkage analysis and fine mapping.
- Dutch Replication Samples: An asthma trio population (407 trios) and a longitudinal general population cohort (Vlagtwedde/Vlaardingen, n=418) were used for replication.
- US Replication Samples: The Children's Respiratory Study (Tucson, AZ, n=329) and three ethnically diverse case-control populations (African-American, Hispanic, and White, totaling 1,437 individuals) were used for replication.
- UK Replication Sample: An asthma family study from Southampton, UK (341 affected sib pair families, n=1508) was used for replication.
No new benchmarks were introduced; the study focused on validating findings in existing, well-characterized populations.
Key Insights and Ideas
- PCDH1 as a Novel BHR Gene: The most significant insight is the identification of PCDH1 as a novel susceptibility gene for BHR. This moves beyond broad chromosomal regions to a specific gene.
- Airway Epithelial Integrity: The expression of PCDH1 in airway epithelial cells and macrophages strongly suggests that its role in BHR is linked to the structural integrity and function of the airway epithelium, the body's first line of defense.
- Early Role in Pathogenesis: The findings imply that PCDH1 dysfunction might play an early role in the development of BHR and asthma, potentially preceding overt symptoms.
- Broad Applicability: The association of PCDH1 variants with BHR was observed in both families with asthma and in general populations, indicating its relevance beyond just asthmatic individuals.
- Potential for Other Diseases: The authors suggest that PCDH1's role in epithelial integrity could make it relevant for other diseases characterized by epithelial dysfunction, such as atopic dermatitis and celiac disease.
Key Results
- Significant Association: In seven out of eight populations studied (totaling 6,168 individuals), PCDH1 gene variants showed a statistically significant association with BHR (p-values ranging from 0.005 to 0.05).
- Specific Variants: The SNP rs3797054 (encoding Ala750Ala) was consistently associated with BHR across multiple populations. A 3-bp insertion/deletion polymorphism (IVS3-116) also showed association in several cohorts.
- Expression Confirmed: PCDH1 mRNA was detected in airway epithelial cells, and PCDH1 protein was consistently expressed in bronchial epithelial cells and macrophages.
- Longitudinal Data: A longitudinal analysis showed that carriers of certain PCDH1 genotypes (CT or TT for rs3797054) had an increased risk of developing BHR over time (p=0.05).
Limitations and Future Work
- Multiple Testing: The authors acknowledge that they did not correct for multiple testing in their initial linkage analysis, which is a standard limitation in genome-wide scans.
- Allelic Heterogeneity: The reasons for variations in the strength of association for different PCDH1 variants across populations are not fully understood and may be due to multiple functional SNPs, linkage disequilibrium, or gene-environment interactions.
- Gene-Environment Interaction: While evidence for gene-environment interaction with environmental tobacco smoke (ETS) was observed in one UK cohort, it was not consistently found in other populations, suggesting a need for further investigation with greater statistical power.
- Functional Studies: The authors emphasize the need for further research to characterize the functional role of the identified PCDH1 gene variants, particularly how they affect epithelial cell adhesion and integrity.
- Indirect BHR Measures: Future work should explore the role of PCDH1 in indirect measures of BHR, such as exercise or adenosine-monophosphate challenges.
- Broader Disease Relevance: The authors suggest investigating PCDH1 in other diseases with epithelial dysfunction, such as atopic dermatitis and celiac disease.
Summary updated